Stock 300511 SHANGHAI XUERONG BIOTECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Shanghai Xuerong Biotechnology Co.,Ltd.

Equities

300511

CNE100002706

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
2.61 CNY -1.14% Intraday chart for Shanghai Xuerong Biotechnology Co.,Ltd. -3.33% -51.21%
Jun. 12 Xuerong Biotechnology Chairman Detained; Shares Plunge 10% MT
Apr. 25 Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Xuerong Biotechnology Chairman Detained; Shares Plunge 10%
MT
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves Board Appointments
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Approves By-Election of Directors
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces Final Cash Dividend Proposal for 2021
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shanghai Xuerong Biotechnology Co.,Ltd. announced that it has received CNY 397.999996 million in funding
CI
Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.
CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Shanghai Xuerong Biotechnology Co.,Ltd. Announces to Implement Final Cash Distribution Plan for 2020, Payable on 14 May 2021
CI
Shanghai Xuerong Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2020
CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Shanghai Xuerong Biotechnology Co., Ltd. Announces Final Cash Dividend for the Year 2020
CI
Shanghai Xuerong Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Shanghai Juhui Biopharmaceutical Industrial Development Co., Ltd. entered into a share transfer agreement to acquire Shanghai Gaorong Biotechnology Co., Ltd. from Shanghai Xuerong Biotechnology Co., Ltd. and Shanghai Xuerong Edible Fungus Co., Ltd for CNY 78 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300511 Stock
  4. News Shanghai Xuerong Biotechnology Co.,Ltd.